Home » Topics » BioWorld Science

BioWorld Science
RSS

New antimicrobial agents targeting bacterial aminopeptidase bMAP

June 22, 2004

New Akt kinase inhibitors emerge from Merck R&D

June 22, 2004

Grelan scientists develop new PDE4 inhibitors for use in respiratory disorders

June 22, 2004

Aventis claims new MMP-13 inhibitors and their use

June 22, 2004

AutoVac vaccines designed for inflammatory and bone diseases

June 22, 2004

Boehringer Ingelheim presents novel xanthine-based DPP-IV inhibitors

June 22, 2004

New antiviral agents prepared and tested at Bayer

June 22, 2004

Further preclinical data on antirheumatic disease activity of AGIX-4207

June 22, 2004

FDA accepts Genmab IND for phase I/II study of HuMax-CD20 in CLL

June 22, 2004

Guilford licenses U.S. rights to GPI-1485 to Symphony Neuro Development Company

June 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...